News Ipca Laboratories Limited Bombay S.E.

Stocks

IPCALAB

INE571A01038

Pharmaceuticals

Market Closed - Bombay S.E. 06:26:56 2026-09-25 EDT			5-day change	1st Jan Change
1,969.50 ^INR	-1.36%		-2.06%	+38.30%

08-14	Ipca Laboratories Limited, Q1 2027 Earnings Call, Aug 14, 2026
08-13	Ipca Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

All News

Mentions Relevance

08-14	Ipca Laboratories Limited, Q1 2027 Earnings Call, Aug 14, 2026
08-13	Ipca Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
06-01	Ipca Laboratories Limited, Q4 2026 Earnings Call, Jun 01, 2026
05-29	Ipca Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
05-29	Ipca Labs March-quarter consol net profit 3 billion rupees	RE
05-29	Ipca Laboratories Limited announces Annual dividend, payable on September 10, 2026	CI
02-16	Ipca Laboratories Limited, Q3 2026 Earnings Call, Feb 16, 2026
02-13	Ipca Labs posts Dec-qtr consol net PAT 3.26 billion rupees	RE
02-13	Ipca Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
12-05	Ipca Laboratories Gets Three Observations from US FDA After Tarapur, India Unit Inspection	MT
12-05	Ipca Labs says US FDA issues Form 483 with three observations	RE
11-17	Nomura Adjusts Ipca Laboratories' Price Target to INR1,725 From INR1,590, Keeps at Buy	MT
11-14	Choice Equity Broking Upgrades Ipca Laboratories to Add from Reduce; Price Target is INR1,410	MT
11-13	Ipca Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
11-13	Ipca Laboratories Limited, Q2 2026 Earnings Call, Nov 13, 2025
11-13	Ipca Labs Sept-quarter consol net PAT 2.83 billion rupees	RE
25-10-17	Ipca Labs says to sell unit in Ankleshwar for 221.5 mln rupees	RE
25-10-16	Suleshvari Pharma agreed to acquire drug intermediates, active pharmaceutical ingredients manufacturing unit of Ipca Laboratories Limited ) for approximately INR 222 million.	CI
25-10-16	Ipca Laboratories Forms Wholly Owned Subsidiary in Germany	MT
25-09-24	Ipca Laboratories Limited Announces Technology Transfer of A Monoclonal Antibody Biosimilar Supercharge Puerto Rico's Biotech Hub	CI
25-08-12	Ipca Laboratories Limited, Q1 2026 Earnings Call, Aug 12, 2025
25-08-11	Ipca Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-08-11	Ipca Laboratories' Consolidated Profit Rises in Fiscal Q1; Shares Down 4%	MT
25-08-11	Ipca Labs June-quarter consol net pat 2.33 billion rupees	RE
25-06-16	Ipca Laboratories Limited Appoints Dr. Nagaji Ambabhai Vekariya as President - CRD Effective June 16, 2025	CI